References:
1. Ben M'rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 2009;88:131-140.
2. Cazzola M, Bergamaschi G, Tonon L, Arbustini E, Grasso M, Vercesi E, et al. Hereditary Hyperferritinemia-Cataract Syndrome: Relationship Between Phenotypes and Specific Mutations in the Iron-Responsive Element of Ferritin Light-Chain mRNA. Blood 1997;90:814-821.
3. Thurlow V, Vadher B, Bomford A, DeLord C, Kannengiesser C, Beaumont C, et al. Two novel mutations in the L ferritin coding sequence associated with benign hyperferritinaemia unmasked by glycosylated ferritin assay. Ann Clin Biochem 2012;49:302-5.
4. Chapman RW, Gorman A, Laulicht M, Hussain MA, Sherlock S, Hoffbrand AV. Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease. J Clin Pathol 1982;35:481-6.
5. Fautrel B, Le Moël G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001;28:322-9.
6. Lebrun D, Mestrallet S, Dehoux M, Golmard JL, Granger B, Georgin-Lavialle S, et al. Validation of the Fautrel classification criteria for adult-onset Still's disease. Semin Arthritis Rheum 2018;47:578-585.
7. Vignes S, Le Moel G, Fautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease. Ann Rheum Dis 2000;59:347-50.
8. Crook MA. Hyperferritinaemia; laboratory implications. Ann Clin Biochem 2012; 49:211-213